Dr. Reshma Ramlal is a hematologist hematologist: (hee-muh-TOL-uh-jist) A doctor who specializes in treating blood diseases and disorders of blood producing organs. -oncologist at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. She specializes in bone marrow bone marrow: The soft, spongy tissue inside most bones. Blood cells are formed in the bone marrow. transplantation and cellular immunotherapy, with a clinical and research focus on allogeneic transplantation for myeloid malignancies, including acute myeloid leukemia acute myeloid leukemia: (uh-KYOOT my-uh-LOYD loo-KEE-mee-uh) A cancer of the blood cells. It happens when very young white blood cells (blasts) in the bone marrow fail to mature. The blast cells stay in the bone marrow and become to numerous. This slows production of red blood cells and platelets. Some cases of MDS become… , myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have low blood cell count for at… , and myeloproliferative neoplasms. She is particularly recognized for advancing safe and effective transplantation in the elderly population, offering individualized treatment plans that emphasize both survival and quality of life.
In her clinical practice, Dr. Ramlal provides expert care in allogeneic stem cell transplantation and the prevention, diagnosis, and treatment of transplant-related early and late complications. She is known for her evidence-based, compassionate approach and for guiding patients and families through every phase of the transplant journey—from pre-transplant evaluation through long-term survivorship.
Nationally, Dr. Reshma Ramlal has made significant contributions to advancing education, quality improvement, and patient outcomes in cancer care. She serves as Chair of the Committee on Education for the American Society for Transplantation and Cellular Therapy (ASTCT) and as Chair-Elect of the Item Writing Task Force for the American Society of Clinical Oncology (ASCO). Through these roles, she helps shape the next generation of standards in bone marrow and stem cell transplantation.
Her recognitions include Leukemia and Lymphoma Society Woman of the Year (Lexington, Kentucky Chapter, 2020), ASCO Educational Scholars Program (2025), and American College of Physicians Florida Chapter Outstanding Resident of the Year for Excellence in Internal Medicine (2012). She also completed the Harvard Medical School Executive Education Training in Artificial Intelligence in Health Care, underscoring her commitment to innovation and the future of precision medicine.
Dr. Ramlal earned her Medical Degree from The University of the West Indies, St. Augustine, graduating first in Medicine and Therapeutics with Honors. She completed her Internal Medicine Residency at the University of Florida College of Medicine in Jacksonville, her Hematology and Oncology Fellowship at Saint Louis University School of Medicine, and an advanced Stem Cell Transplantation and Cellular Therapy Fellowship at The University of Texas MD Anderson Cancer Center.
Tampa, FL 33612
United States